赋予个性化医学的权力:在临床实践中释放患者衍生扩展的潜力
Oliwia Piwocka1,2,3, Wiktoria M Suchorska1,3, Katarzyna Kulcenty3
1Department of Electroradiology, Poznan University of Medical Sciences, 61-701 Poznan, Poland.
EXCLI journal
|February 12, 2024
概括
患者衍生扩展剂 (PDEs) 为个性化癌症医学提供了一种有前途的方法. 这些模型有助于研究瘤行为和药物反应,为个别患者推进量身定制的治疗方法.
科学领域:
- 在瘤学瘤学.
- 翻译医学是一种翻译医学.
- 生物技术是生物技术.
背景情况:
- 癌症分子生物学方面的重大进展已经产生了拯救生命的治疗方法.
- 标准的癌症疗法往往会引起副作用,需要个性化医疗.
- 瘤和患者的异质性推动了对个性化治疗策略的需求.
研究的目的:
- 总结一下患者衍生实验剂 (PDEs) 的最新进展.
- 突出PDEs在个性化癌症治疗中的临床实用性.
- 讨论各种培养方法和PDEs在固体瘤建模中的应用.
主要方法:
- 审查不同的患者衍生式拓展剂 (PDE) 培养技术,包括自由浮动,网格和海绵支架方法.
- 讨论使用PDEs的固体瘤模型.
- 评估PDE活力,特征和药物反应的试验概述.
主要成果:
- 各种PDE培养方法支持长期活力,营养供应和组织完整性.
- 在研究瘤行为和药物敏感性方面,PDEs是有价值的模型.
- 已建立的测定方法可以对PDE特征和治疗反应进行全面分析.
结论:
- 患者衍生扩展剂 (PDEs) 在个性化癌症医学中显示出临床应用的巨大潜力.
- 先进的培养技术提高了PDE在临床前药物测试中的实用性.
- PDEs有助于研究瘤异质性和个体药物反应,为量身定制的疗法铺平道路.
相关概念视频
Induced Pluripotent Stem Cells
22.9K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
22.9K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Stem Cell Culture
5.2K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.2K
Embryonic Stem Cells
27.5K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
27.5K


